Selected article for: "long term and respiratory system"
Author: Alyammahi, Shatha K.; Abdin, Shifaa M.; Alhamad, Dima W.; Elgendy, Sara M.; Altell, Amani T.; Omar, Hany A.
Title: The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence mechanism and therapeutic modalities
  • Cord-id: yv4d8ka8
  • Document date: 2020_11_29
    • ID: yv4d8ka8
    Snippet: The devastating pandemic of coronavirus disease 2019 (COVID-19) has caused thousands of deaths and left millions of restless patients suffering from its complications. Increasing data indicate that the disease presents in a severe form in patients with pre-existing chronic conditions like cardiovascular diseases, diabetes, respiratory system diseases, and renal diseases. This indicates that these patients seem to be more susceptible to COVID-19 and have higher mortality rates compared to patient
    Document: The devastating pandemic of coronavirus disease 2019 (COVID-19) has caused thousands of deaths and left millions of restless patients suffering from its complications. Increasing data indicate that the disease presents in a severe form in patients with pre-existing chronic conditions like cardiovascular diseases, diabetes, respiratory system diseases, and renal diseases. This indicates that these patients seem to be more susceptible to COVID-19 and have higher mortality rates compared to patients with no comorbid conditions. Several factors can explain the heightened susceptibility to and fatal presentation of COVID-19 in these patients, for example, the enhanced expression of the angiotensin-converting enzyme-2 receptor (ACE2) in specific organs, cytokine storm, and drug interactions contribute to the increased morbidity and mortality. Adding to the findings that individuals with pre-existing conditions may be more susceptible to COVID-19, it has also been shown that COVID-19 can induce chronic diseases in previously healthy patients. Therefore, understanding the interlinked relationship between COVID-19 and chronic diseases helps in optimizing the management of susceptible patients. This review comprehensively described the molecular mechanisms that contribute to worse COVID-19 prognosis in patients with pre-existing comorbidities such as diabetes, cardiovascular diseases, respiratory diseases, gastrointestinal and renal diseases, blood disorders, autoimmune diseases and finally, obesity. It also focused on how COVID-19 could, in some cases, lead to chronic conditions as a result of long-term multi-organ damage. Lastly, this work carefully discusses the tailored management plans for each specific patient population, aiming to achieve the best therapeutic outcome with minimum complications.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acs acute chest syndrome: 1
    • abdominal pain and acute aki kidney injury: 1, 2, 3, 4, 5, 6
    • abdominal pain and acute chest syndrome: 1, 2
    • abdominal pain and acute kidney injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • abdominal pain and acute kidney injury aki: 1, 2, 3, 4, 5, 6
    • abdominal pain and acute lung damage: 1
    • abdominal pain and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • abdominal pain and acute respiratory distress syndrome ards: 1, 2, 3, 4
    • abdominal pain and adipose tissue: 1, 2, 3
    • abdominal pain and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
    • abdominal pain and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • abdominal pain and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • abdominal pain and low prevalence: 1, 2, 3, 4
    • abdominal pain and lung damage: 1
    • abdominal pain and lung function: 1, 2, 3, 4
    • abdominal pain and lung infection: 1, 2, 3, 4
    • abdominal pain and lung injury: 1, 2, 3, 4, 5
    • abdominal pain and lung tissue: 1, 2